
What’s the difference between recreational and therapeutic psychedelic use? 5 Questions with experimental psychologist Harriet de Wit
De Wit discusses the difficulty of finding out what a drug does, outside of its context.
An independent journalism newsletter supported by the U.C. Berkeley Center for the Science of Psychedelics
Live Last read · last published · next check

De Wit discusses the difficulty of finding out what a drug does, outside of its context.

Plus: Pharmaceutical giant Eli Lilly makes a psychedelics acquisition; Cardiovascular safety is top of mind for psychedelics researchers

Ham discusses doing interviews with clinical trial participants who didn’t experience substantial benefits.

Following toad poachers across the Sonoran Desert

Hashemi discusses her approach to drug education and what students want to know about psychedelics.

Romero discusses what a recently discovered manuscript reveals about peyote in the 17th century.

Dupuis discusses how auditory hallucinations during psychedelic trips have been overlooked.

Plus: Compass Pathways announces new Phase 3 results, and Lawsuit against LSD company Definium is dismissed

Fan discusses making her feature documentary film about wild mushroom foragers and what she discovered about place and belonging along the way.

Kangaslampi discusses the need to study autobiographical memories that may emerge during trips.